Indication
Malignant tumor of testis
A malignant tumor of the testis, commonly known as testicular cancer, is a neoplastic disease arising within the male reproductive system, primarily affecting males between the ages of 15 and 44. Read more about Malignant tumor of testis
4 drugs 4 manufacturers
Drugs that treat it
Common Malignant tumor of testis therapies.
OPZELURA (vinblastine sulfate)
VINBLASTINE SULFATE
VINBLASTINE SULFATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA malignant tumor of the testis, commonly known as testicular cancer, is a neoplastic disease arising within the male reproductive system, primarily affecting males between the ages of 15 and 44.
The overwhelming majority originate from germ cells and are broadly classified into seminomas and nonseminomas, though rare malignancies can arise from sex cord-stromal tissues.
Pathophysiologically, these tumors frequently present as a painless testicular nodule or scrotal swelling, with progression typically characterized by lymphatic spread to the retroperitoneal lymph nodes and occasional hematogenous dissemination to distant sites such as the lungs.
Many subtypes are marked by aberrant serum tumor markers, including alpha-fetoprotein, human chorionic gonadotropin, and lactate dehydrogenase, which assist in clinical staging and therapeutic monitoring.
- nih.gov
A malignant tumor of the testis, commonly known as testicular cancer, is a neoplastic disease arising within the male reproductive system, primarily affecting males between the ages of 15 and 44 The overwhelming majority originate from germ cells and are broadly classified into seminomas and nonseminomas, though rare malignancies can arise from sex cord-stromal tissues
- clevelandclinic.org
A malignant tumor of the testis, commonly known as testicular cancer, is a neoplastic disease arising within the male reproductive system, primarily affecting males between the ages of 15 and 44 Pathophysiologically, these tumors frequently present as a painless testicular nodule or scrotal swelling, with progression typically characterized by lymphatic spread to the retroperitoneal lymph nodes and occasional hematogenous dissemination to distant sites such as the lungs
- cancer.gov
The overwhelming majority originate from germ cells and are broadly classified into seminomas and nonseminomas, though rare malignancies can arise from sex cord-stromal tissues
- erlanger.org
The overwhelming majority originate from germ cells and are broadly classified into seminomas and nonseminomas, though rare malignancies can arise from sex cord-stromal tissues
- nih.gov
Pathophysiologically, these tumors frequently present as a painless testicular nodule or scrotal swelling, with progression typically characterized by lymphatic spread to the retroperitoneal lymph nodes and occasional hematogenous dissemination to distant sites such as the lungs Many subtypes are marked by aberrant serum tumor markers, including alpha-fetoprotein, human chorionic gonadotropin, and lactate dehydrogenase, which assist in clinical staging and therapeutic monitoring
- mayoclinic.org
Pathophysiologically, these tumors frequently present as a painless testicular nodule or scrotal swelling, with progression typically characterized by lymphatic spread to the retroperitoneal lymph nodes and occasional hematogenous dissemination to distant sites such as the lungs
- ucla.edu
Many subtypes are marked by aberrant serum tumor markers, including alpha-fetoprotein, human chorionic gonadotropin, and lactate dehydrogenase, which assist in clinical staging and therapeutic monitoring
Personalize your experience
Follow Malignant tumor of testis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.